M&A Deal Summary |
|
|---|---|
| Date | 2019-09-10 |
| Target | BioVectra |
| Sector | Life Science |
| Buyer(s) | H.I.G. Private Equity |
| Sellers(s) | Questcor Pharmaceuticals |
| Deal Type | Divestiture |
| Deal Value | 250M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1993 |
| PE ASSETS | 65.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
HIG Private Equity is the private equity arm of HIG Capital LLC. The firm focuses on management buyouts, growth equity investments, and recapitalizations of middle market companies with an enterprise value of $50 - $1000 million. The Firm also will consider add-on acquisitions, industry consolidations, going-privates, and corporate divestitures. Sectors of interest include aerospace, building materials, business services, consumer products, distribution, healthcare, infrastructure, contracting, manufacturing, media, oil & gas services, IT, and transportation. HIG was formed in 1993 and has offices in Miami, Atlanta, Boston, and San Francisco. HIG's European affiliate is HIG Europe with offices in London, Hamburg, and Paris.
| DEAL STATS | # |
|---|---|
| Overall | 253 of 369 |
| Sector (Life Science) | 3 of 6 |
| Type (Divestiture) | 30 of 45 |
| State (Prince Edward Island) | 1 of 1 |
| Country (Canada) | 12 of 14 |
| Year (2019) | 15 of 18 |
| Size (of disclosed) | 11 of 21 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-09-04 |
Nadir
São Paulo, Brazil Nadir is a glass tableware producer in Brazil and the 6th largest in the world. Nadir provides high-quality products and long-standing relationships with all major distributors and retailers. Nadir was founded in 1912 and is based in Sao Paulo, Brazil. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-09-24 |
RxStrategies
Boca Raton, Florida, United States RxStrategies provides the federally qualified community health centers (FQHC), other qualified entities and the pharmacy partners with a full turn-key solution for the implementation and on-going management of the 340B discount prescription drug program. RxStrategies was founded in 2003 and is based in Boca Raton, Florida. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company that provides drugs for the treatment of autoimmune and inflammatory disorders.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (Prince Edward Island) | 1 of 1 |
| Country (Canada) | 1 of 1 |
| Year (2019) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-11 |
Rights to Synacthen
United States Synacthen® and Synacthen Depot® in certain countries outside the U.S. Available in more than forty countries for multiple indications, Synacthen (tetracosactide) is a synthetic 24 amino acid melanocortin receptor agonist. Synacthen Depot is a depot formulation of Synacthen. The products are approved outside the U.S. for certain autoimmune and inflammatory conditions, but have never been developed or approved for patients in the U.S. |
Buy | $60M |
